New Study Reveals How Muscle Cells Drive Coronary Artery Disease Risk

A new study has uncovered how dynamic changes in vascular smooth muscle cells (VSMCs) contribute to coronary artery disease (CAD). Published in Nature Communications, the research challenges the long-held view of VSMCs as passive structures, revealing their active role in disease progression. The findings highlight potential therapeutic targets for treating heart conditions.

For years, VSMCs were seen as static components of blood vessels. This study now shows they adapt to environmental signals by shifting between different states. Researchers used computational models to track these transitions and identify molecular pathways controlling VSMC behaviour.

The team discovered that certain transitional states of VSMCs are linked to a higher risk of coronary disease. When these cells shift toward pro-inflammatory forms, they worsen vascular inflammation and destabilise arterial plaques. This increases the likelihood of heart attacks and other cardiac complications.

Key regulators, such as the transcription factors KLF4 and myocardin, act as switches between contractile and synthetic VSMC states. The study also found that genetic risk factors for CAD overlap with these VSMC trajectory changes, suggesting genes influence how the cells evolve. Epigenetic changes, like altered histone acetylation, were shown to lock VSMCs into harmful states, offering new avenues for drug development.

To confirm their findings, the researchers tested in vivo models of coronary artery disease. These experiments supported the single-cell data, reinforcing the idea that targeting VSMC transitions could lead to new treatments.

The study provides a clearer picture of how VSMC plasticity drives coronary artery disease. By pinpointing molecular and genetic factors behind these cell changes, it opens doors for therapies that could stabilise VSMCs and reduce CAD risk. Further research may now focus on developing interventions based on these epigenetic and transcriptional insights.